Summary of Study ST001673

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001076. The data can be accessed directly via it's Project DOI: 10.21228/M8MH5J This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001673
Study TitleTargeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS
Study SummaryA group of sequentially-acting enzymes operating at the branchpoint among sphingolipid synthetic pathways binds the Golgi-localised oncoprotein GOLPH3. GOLPH3 sorts these enzymes into vesicles for intra-Golgi retro-transport, acting as a component of the cisternae inter-conversion mechanisms. Through these effects, GOLPH3 controls the sub-Golgi localisation, and the lysosomal degradation rate of specific enzymes. Here we evaluated the impact of overexpressing or silencing GOLPH3 or its client enzyme lactosylceramide synthase (LCS) on the sphingolipid composition of HeLa cells by targeted lipid analysis.
Institute
École polytechnique fédérale de Lausanne (EPFL)
DepartmentIBI
LaboratoryUPDANGELO
Last NameD'Angelo
First NameGiovanni
AddressStation 15, Lausanne, Vaud, 1015, Switzerland
Emailgiovanni.dangelo@epfl.ch
Phone+41 216934276
Submit Date2021-01-29
Raw Data AvailableYes
Raw Data File Type(s)raw(Thermo)
Analysis Type DetailLC-MS
Release Date2021-02-26
Release Version1
Giovanni D'Angelo Giovanni D'Angelo
https://dx.doi.org/10.21228/M8MH5J
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001076
Project DOI:doi: 10.21228/M8MH5J
Project Title:Targeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS
Project Summary:A group of sequentially-acting enzymes operating at the branchpoint among sphingolipid synthetic pathways binds the Golgi-localised oncoprotein GOLPH3. GOLPH3 sorts these enzymes into vesicles for intra-Golgi retro-transport, acting as a component of the cisternae inter-conversion mechanisms. Through these effects, GOLPH3 controls the sub-Golgi localisation, and the lysosomal degradation rate of specific enzymes. Here we evaluated the impact of overexpressing or silencing GOLPH3 or its client enzyme lactosylceramide synthase (LCS) on the sphingolipid composition of HeLa cells by targeted lipid analysis.
Institute:École polytechnique fédérale de Lausanne (EPFL)
Department:IBI
Laboratory:UPDANGELO
Last Name:D'Angelo
First Name:Giovanni
Address:Station 15, Lausanne, Vaud, 1015, Switzerland
Email:giovanni.dangelo@epfl.ch
Phone:+41 216934276

Subject:

Subject ID:SU001750
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606

Factors:

Subject type: Cultured cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Treatment
SA154464GOLPH3_OE_1GOLPH3 overexpression
SA154465GOLPH3_OE_3GOLPH3 overexpression
SA154466GOLPH3_OE_2GOLPH3 overexpression
SA154467GOLPH3_KD_3GOLPH3 silencing
SA154468GOLPH3_KD_1GOLPH3 silencing
SA154469GOLPH3_KD_2GOLPH3 silencing
SA154470LCS_OE_2LCS overexpression
SA154471LCS_OE_1LCS overexpression
SA154472LCS_OE_3LCS overexpression
SA154473LCS_KD_3LCS silencing
SA154474LCS_KD_2LCS silencing
SA154475LCS_KD_1LCS silencing
SA154476CTRL_2no treatment
SA154477CTRL_1no treatment
SA154478CTRL_3no treatment
Showing results 1 to 15 of 15

Collection:

Collection ID:CO001743
Collection Summary:Cells were washed in ice cold PBS and collected by scaling
Sample Type:HeLa cells

Treatment:

Treatment ID:TR001763
Treatment Summary:Cells were treated to overexposes or down regulate GOLPH3 or LCS

Sample Preparation:

Sampleprep ID:SP001756
Sampleprep Summary:Samples were fortified with an Internal standard Mix and lipids were extracted twice with an extraction mix consisting of 85:15 Ethyl acetate 70% Isopropanol. All lipids that were used in the Internal standard mix and in the Calibration mixes were purchased from Avanti Polar Lipids Inc. After evaporating the cell extract to dryness, the samples were reconstituted in the mobile phase.

Combined analysis:

Analysis ID AN002731
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Accela 1250
Column Thermo Accucore C18 (100 x 2.1mm,2.6um)
MS Type ESI
MS instrument type Triple quadrupole
MS instrument name Thermo Quantum Ultra
Ion Mode POSITIVE
Units pmoles

Chromatography:

Chromatography ID:CH002017
Chromatography Summary:Samples were analyzed with a Quantum Ultra triple quadrupole mass spectrometer connected to an Accela HPLC and Accela autosampler using a solvent gradient. Ceramides identity was achieved through MRM analysis with soft fragmentation. Quantitative analysis is based on calibration curves generated for each ceramide. J. Bielawski et al. / Methods 39 (2006) 82–91
Instrument Name:Thermo Accela 1250
Column Name:Thermo Accucore C18 (100 x 2.1mm,2.6um)
Chromatography Type:Reversed phase

MS:

MS ID:MS002528
Analysis ID:AN002731
Instrument Name:Thermo Quantum Ultra
Instrument Type:Triple quadrupole
MS Type:ESI
MS Comments:Samples were analyzed with a Quantum Ultra triple quadrupole mass spectrometer connected to an Accela HPLC and Accela autosampler using a solvent gradient. Ceramides identity was achieved through MRM analysis with soft fragmentation. Quantitative analysis is based on calibration curves generated for each ceramide. J. Bielawski et al. / Methods 39 (2006) 82–91
Ion Mode:POSITIVE
  logo